Skip to content

Concentrix

US · CNXC #2960 by market cap Listed 2015
29.26 +0.70 +2.45%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 28.52 -0.14%
After-hours 29.26 0.00%
Overnight 28.56 0.00%
33.8820.6329.262026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on CNXC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +3.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 13.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B-
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A+

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 4.8x Better than 98%
Price / Sales 0.2x Better than 98%
Growth B-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.8% Better than 77%
Net income CAGR (3Y) -14.8% Better than 22%
Free cash flow CAGR (3Y) 7.5% Better than 49%
Profitability D+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 35.0% Better than 40%
Operating margin 6.2% Better than 39%
Net margin -13.1% Better than 15%
Return on equity -37.8% Better than 11%
Return on invested capital -13.2% Better than 16%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 15.2% Better than 94%
6-month return 12.9% Better than 76%
12-month return (ex latest month) -3.7% Better than 30%
Distance below 52-week high 31.3% Better than 41%
Financial Health C-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.4x Better than 37%
Debt to assets 43.1% Better than 23%
Interest coverage -3.1x Better than 19%
Free cash flow / net income 170.7% Better than 71%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 66.7% Better than 41%
Upside to average target 18.5% Better than 30%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -10.57%
1M +1.13%
3M +16.11%
6M +19.47%
YTD -26.80%
1Y -8.76%
3Y -65.69%
5Y -82.55%

Key statistics

Price & volume

Prev close
28.56
Open
28.50
Day range
28.35 - 30.13
Avg price
29.39
Volume
693.81K
Turnover
20.39M
Amplitude
6.25%
52-week range
18.60 - 42.58

Valuation

P/E
-1.44
P/E (TTM)
-0.76
P/B
1.01
EPS
-20.36
Net profit
-1.24B
Net assets
1.77B

Share structure

Market cap
1.79B
Float cap
1.64B
Shares out
61.11M
Float shares
56.04M

Dividend & listing

Dividend (TTM)
1.44
Listing date
2015-07-01
52-week range 44% of range
18.60 42.58

31.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-8.97M net over the window

Short interest

Shares short
8.01M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Concentrix (CNXC)?

Concentrix last traded at 29.26. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Concentrix's market cap?

About 1.79B.

What is the P/E ratio of Concentrix?

The trailing twelve-month P/E is -0.76, below its own 5-year average of 2.63 — toward the bottom of its historical range (17.07% percentile). See the Valuation tab for the full history.

Does Concentrix pay a dividend?

Yes. The trailing dividend yield is 4.92%. The 2025 payout was up 9.5% from 2024. See the Dividends tab for the full payment history.

Is Concentrix a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 34.67, which implies 18.5% upside from the current price. This is not investment advice.

What is Concentrix's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Concentrix a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Concentrix discussion 0 comments

Add a comment